Mechanical circulatory support in acute heart failure

Texas Heart Institute Journal

Volumn 39, Issue 6, 2012, Pages 854-855

  Gregoric, Igor D ^a  

^a UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

Adult therapy; Cardiac output; Cardiogenic therapy; Heart catheterization; Heart failure therapy; Heart assist devices; Intra aortic balloon pumping; Low therapy; Myocardial reperfusion; Respiratory distress syndrome; Shock

Indexed keywords

ANTICOAGULANT AGENT;

ARTICLE; ASSISTED CIRCULATION; CANNULATION; CARDIOGENIC SHOCK; DISEASE SEVERITY; HEART CATHETERIZATION; HEART OUTPUT; HUMAN; OUTCOME ASSESSMENT; SEVERE REFRACTORY CARDIOGENIC SHOCK; SURVIVAL; VENTRICULAR ASSIST DEVICE;

EID: 84874065148     PISSN: 07302347     EISSN: 15266702     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Wu AH, Parsons L, Every NR, Bates ER; Second National Registry of Myocardial Infarction. Hospital outcomes in patients presenting with congestive heart failure complicating acute myocardial infarction: a report from the Second National Registry of Myocardial Infarction (NRMI-2). J Am Coll Cardiol 2002;40(8):138913-94.
2. Topalian S, Ginsberg F, Parrillo JE. Cardiogenic shock. Crit Care Med 2008;36(1 Suppl):S66-s74.
3. Jeger RV, Harkness SM, Ramanathan K, Buller CE, Pfisterer ME, Sleeper LA, et al. Emergency revascularization in patients with cardiogenic shock on admission: a report from the SHOCK trial and registry. Eur Heart J 2006;27(6):664-670.
4. Webb JG, Lowe AM, Sanborn TA, White HD, Sleeper LA, Carere RG, et al. Percutaneous coronary intervention for cardiogenic shock in the SHOCK trial. J Am Coll Cardiol 2003; 42(8):1380-6.
5. Menon V, Fincke R. Cardiogenic shock: a summary of the randomized SHOCK trial. Congest Heart Fail 2003;9(1):35-39.
6. Kantrowitz A, Wasfie T, Freed PS, Rubenfire M, Wajszczuk W, Schork MA. Intraaortic balloon pumping 1967 through 1982: analysis of complications in 733 patients. Am J Cardiol 1986;57(11):976-983.
7. Ferguson JJ 3rd, Cohen M, Freedman RJ Jr, Stone GW, Miller MF, Joseph DL, Ohman EM. The current practice of intraaortic balloon counterpulsation: results from the Benchmark Registry. J Am Coll Cardiol 2001;38(5):1456-62.
8. Moran JL, Chalwin RP, Graham PL. Extracorporeal membrane oxygenation (ECMO) reconsidered. Crit Care Resusc 2010;12(2):131-135.
9. Formica F, Corti F, Avalli L, Paolini G. ECMO support for the treatment of cardiogenic shock due to left ventricular free wall rupture. Interact Cardiovasc Thorac Surg 2005;4(1):30-32.
10. Seyfarth M, Sibbing D, Bauer I, Frohlich G, Bott-Flugel L, Byrne R, Dirschinger J, Kastrati A, Schomig A. A randomized clinical trial to evaluate the safety and efficacy of a percutaneous left ventricular assist device versus intra-aortic balloon pumping for treatment of cardiogenic shock caused by myocardial infarction. J Am Coll Cardiol 2008;52(19):1584-1588.
11. Kar B, Adkins LE, Civitello AB, Loyalka P, Palanichamy N, Gemmato CJ, et al. Clinical experience with the Tandem- Heart percutaneous ventricular assist device. Tex Heart Inst J 2006;33(2):111-115.
12. Kar B, Gregoric ID, Basra SS, Idelchik GM, Loyalka P. The percutaneous ventricular assist device in severe refractory cardiogenic shock. J Am Coll Cardiol 2011;57(6):688-696.